Effect of Fluoxetine Administration on Clinical and Echocardiographic Findings in Patients with Mitral Valve Prolapse and Generalized Anxiety Disorder
Randomized Clinical Trial
Keywords:
Mitral valve prolapse, Anxiety, Fluoxetine, PropranololAbstract
Background: Mitral valve prolapse (MVP) is accompanied by mental disorders including anxiety, which has similar presentations as MVP. It is hypothesised that treatment of anxiety might reduce the symptoms of MVP. Objective: The aim of this study was to assess the clinical and echocardiographic effects of fluoxetine administration in patients with MVP and anxiety.
Methods: This randomized clinical trial was conducted on patients with documented MVP and generalised anxiety disorder (GAD) who were referred to Mashhad University of Medical Sciences cardiology clinics, Mashhad, Iran in 2015. Subjects were randomly assigned to intervention group who received propranolol and fluoxetine (both at 10 mg/day) and control group who received 10 mg/day propranolol. Assessments included echocardiography and GAD-7 questionnaire and rating of chest pain, that were performed at baseline and then weekly for 4 weeks. Analysis was performed using the Mann-Whitney U test and Two-way Repeated Measures Analysis of Variance (ANOVA).
Results: Sixty patients (25 male/ 35 female) with a mean age of 22.9 ± 2.5 years were studied in two groups of intervention (n = 30) and control (n = 30). GAD score was significantly higher in the intervention group (17.37 ± 1.61) compared with the control group (14.17 ± 0.83) (p<0.001). No significant difference was observed for changes in left atrium diameter, mitral annular diameter, left ventricular diameter or ejection fraction (p>0.05). Pain severity was reduced significantly more in control group (3.27 ± 1.26) compared to intervention group (2.80 ± 0.85) after treatment (p<0.001).
Conclusions: This study revealed that the co-administration of fluoxetine and propranolol may not only have no effective in improving echocardiographic changes of MVP but may also aggravate subjective findings of patients with MVP and GAD.
Trial registration: The trial is registered at the Iranian Clinical Trial Registry (IRCT.ir) with the IRCT identification number IRCT2014102819721N1.
Funding: This research has been financially supported by Research Council of Sabzevar University of Medical Sciences.
References
Joudinaud TM, Kegel CL, Flecher EM, Weber PA, Lansac E, Hvass U, et al. The papillary muscles as
shock absorbers of the mitral valve complex. An experimental study. Eur J Cardiothorac Surg. 2007; 32(1):
-101. doi: 10.1016/j.ejcts.2007.03.043. PMID: 17512209.
Devereux RB, Jones EC, Roman MJ, Howard BV, Fabsitz RR, Liu JE, et al. Prevalence and correlates of
mitral valve prolapse in a population-based sample of American Indians: the Strong Heart Study. Am J
Med. 2001; 111(9): 679-85. doi: 10.1016/S0002-9343(01)00981-0. PMID: 11747846.
Avierinos JF, Inamo J, Grigioni F, Gersh B, Shub C, Enriquez-Sarano M. Sex Differences in the
Morphology and Outcomes of Mitral Valve Prolapse. Ann Intern Med. 2008; 149(11): 787-95. doi:
7326/0003-4819-149-11-200812020-00003. PMID: 19047025, PMCID: PMC2897166.
Delling FN, Vasan RS. Epidemiology and Pathophysiology of Mitral Valve Prolapse New Insights Into
Disease Progression, Genetics, and Molecular Basis. Circulation. 2014; 129(21): 2158-70. doi:
1161/CIRCULATIONAHA.113.006702. PMID: 24867995, PMCID: PMC4052751.
Addetia K, Mor-Avi V, Weinert L, Salgo IS, Lang RM. A New Definition for an Old Entity: Improved
Definition of Mitral Valve Prolapse Using Three-Dimensional Echocardiography and Color-Coded
Parametric Models. J Am Soc Echocardiogr. 2014; 27(1): 8-16. doi: 10.1016/j.echo.2013.08.025. PMID:
Iung B, Gohlke-Bärwolf C, Tornos P, Tribouilloy C, Hall R, Butchart E, et al. Recommendations on the
management of the asymptomatic patient with valvular heart disease. Eur Heart J. 2002; 23(16): 1253-66.
doi: 10.1053/euhj.2002.332. PMID: 12698958.
Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on
the management of valvular heart disease (version 2012). Eur Heart J. 2012; 33(19): 2451-96. doi:
1093/eurheartj/ehs109. PMID: 22922415.
Filho AS, Maciel BC, Romano MM, Lascala TF, Trzesniak C, Freitas-Ferrari MC, et al. Mitral valve
prolapse and anxiety disorders. Br J Psychiatry. 2011; 199(3): 247-8. doi: 10.1192/bjp.bp.111.091934.
PMID: 21881100.
Zinchenko YP, Pervichko EI, Martynov AI. Psychological underpinning of personalized approaches in
modern medicine: syndrome analysis of mitral valve prolapsed patients. Psychol Russ State Art. 2013;
(2): 89-102. doi: 10.11621/pir.2013.0208.
Zinchenko YP, Pervichko EI. Qualitative Characteristics of Emotion Regulation Process in Adolescents
with Mitral Valve Prolapse. Procedia - Soc Behav Sci. 2014; 146: 76-82. doi:
1016/j.sbspro.2014.08.089.
Combs RL, Shah PM, Klorman RS, Klorman R. Effects of induced psychological stress on click and
rhythm in mitral valve prolapse. Am Heart J. 1980; 99(6): 714-21. doi: 10.1016/0002-8703(80)90620-1.
PMID: 7377092.
Hu X, Zhao Q. Autonomic dysregulation as a novel underlying cause of mitral valve prolapse: A
hypothesis. Med Sci Monit. 2011; 17(9): 27-31. doi: 10.12659/msm.881918. PMID: 21873953, PMCID:
PMC3560509.
Lung FW, Cheng CT, Chang WT, Shu BC. Anxiety and mood disorder in young males with mitral valve
prolapse. J Multidiscip Healthc. 2008; 1: 89-92. PMID: 21197339, PMCID: PMC3004540.
Pervichko E, Zinchenko Y, Martynov A. EPA-0581 - Long-term integrative psychotherapy of anxiety
disorders in mitral valve prolapse patients: the factors of mental health improvement. Eur Psychiatry. 2014;
(1): 1. doi: 10.1016/S0924-9338(14)77970-2.
Pervichko EI, Zinchenko YP, Martynov AI. 2865 – Assesment of quality of life at mitral valve prolapse
patients suffering anxiety disorders. Eur Psychiatry. 2013; 28(1): 1. doi: 10.1016/S0924-9338(13)77444-3.
Baldwin DS, Anderson IM, Nutt DJ, Allgulander C, Bandelow B, den Boer JA, et al. Evidence-based
pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive
disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J
Psychopharmacol. 2014; 28(5): 403-39. doi: 10.1177/0269881114525674. PMID: 24713617.
Maréchaux S, Jeu A, Jobic Y, Ederhy S, Donal E, Réant P, et al. Impact of selective serotonin reuptake
inhibitor therapy on heart valves in patients exposed to benfluorex: A multicentre study. Arch Cardiovasc
Dis. 2013; 106(6-7): 349-56. doi: 10.1016/j.acvd.2013.04.006. PMID: 23876809.
Shahzad N, Ahmad J, Khan W, Al-Ghamdi SS, Ain MR, Ibrahim IAA, et al. Interactions of atenolol with
alprazolam/escitalopram on anxiety, depression and oxidative stress. Pharmacol Biochem Behav. 2014;
: 79-84. doi: 10.1016/j.pbb.2013.12.015. PMID: 24361783.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder:
the GAD-7. Arch Intern Med. 2006; 166(10): 1092-7. doi: 10.1001/archinte.166.10.1092. PMID:
Naeenyian MR, Shairi MRS, Sharifi M, Hadian M. Evaluation of reliability and validity of short
Generalized Anxiety Disorder (GAD-7). Clin Psychol Personal. 2010; 3(4): 41-50.
Zito C, Carerj S, Todaro MC, Cusmà-Piccione M, Caprino A, Di Bella G, et al. Myocardial deformation
and rotational profiles in mitral valve prolapse. Am J Cardiol. 2013; 112(7): 984-90. doi:
1016/j.amjcard.2013.05.031. PMID: 23800550.
Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, et al. Usefulness of atrial deformation
analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve
operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 2013; 111(4):
-601. doi: 10.1016/j.amjcard.2012.10.049. PMID: 23211360.
Boudoulas KD, Pitsis AA, Boudoulas H. Floppy Mitral Valve (FMV)–Mitral Valve Prolapse (MVP)-Mitral
Valvular Regurgitation and FMV/MVP Syndrome. Hellenic J Cardiol. 2016; 57(2): 73-85. doi:
1016/j.hjc.2016.03.001. PMID: 27445020.
Hu X, Wang HZ, Liu J, Chen AQ, Ye XF, Zhao Q. A novel role of sympathetic activity in regulating mitral
valve prolapse. Circ J. 2014; 78(6): 1486-93. PMID: 24670922.
Steenen SA, van Wijk AJ, van der Heijden GJ, van Westrhenen R, de Lange J, de Jongh A. Propranolol for
the treatment of anxiety disorders: Systematic review and meta-analysis. J Psychopharmacol. 2016; 30(2):
-39. doi: 10.1177/0269881115612236. PMID: 26487439, PMCID: PMC4724794.
Theofilogiannakos EK, Boudoulas KD, Gawronski BE, Langaee TY, Dardas PS, Ninios V, et al. Floppy
mitral valve/mitral valve prolapse syndrome: Beta-adrenergic receptor polymorphism may contribute to the
pathogenesis of symptoms. J Cardiol. 2015; 65(5): 434-8. doi: 10.1016/j.jjcc.2014.07.020. PMID:
George N, Abdallah J, Maradey-Romero C, Gerson L, Fass R. Review article: the current treatment of non- cardiac chest pain. Aliment Pharmacol Ther. 2016; 43(2): 213-39. doi: 10.1111/apt.13458. PMID:
Varia I, Logue E, O’connor C, Newby K, Wagner HR, Davenport C, et al. Randomized trial of sertraline in
patients with unexplained chest pain of noncardiac origin. Am Heart J. 2000; 140(3): 367-72. doi:
1067/mhj.2000.108514. PMID: 10966532.
Conner R, Sheikh M, Grubb B. Postural orthostatic tachycardia syndrome (POTS): Evaluation and
management. Br J Med Pract. 2012; 5(4): 540.
Gollan JK, Fava M, Kurian B, Wisniewski SR, Rush AJ, Daly E, et al. What are the clinical implications of
new onset or worsening anxiety during the first two weeks of SSRI treatment for depression? Depress
Anxiety. 2012; 29(2): 94-101. doi: 10.1002/da.20917. PMID: 22147631, PMCID: PMC3860362.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
